Semiconductors & Electronics Global On demand · 24-48h

Global Streptavidin SPR Chip Market Strategic Research Report

Global Streptavidin SPR Chip Market Strategic Research Repor…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Streptavidin SPR Chip Market
$51.852025
7.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Pre-Immobilized Streptavidin, On-Chip Streptavidin Kit, Regenerable Streptavidin, Custom Streptavidin Surface, Other Capture Surface

By Application: Protein Kinetics, Small-Molecule Screening, Antibody Characterization, Nucleic Acid Binding, Peptide Binding, Biomarker Assay Development, Biosensor Surface Development

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cytiva, Sartorius, Nicoya, XanTec, BioNavis, Biosensing Instrument, Reichert, Carterra, Malvern Panalytical, Polariton Life

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 98 pages
Market size 2025
$51.85
Million USD
Forecast CAGR
7.5%
2025-2032
Forecast 2032
$86
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Streptavidin SPR Chip market size is predicted to grow from US$ 51.85 million in 2025 to US$ 84.40 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.

Streptavidin SPR chips are SPR consumables in which streptavidin is pre-immobilized or forms a streptavidin capture layer on gold films, prisms, or sensor substrates via accompanying reagents. They are used for high-affinity capture of biotinylated proteins, peptides, nucleic acids, glycans, and other ligands, enabling affinity, kinetics, and screening analyses. The product’s gross margin is approximately 62%.

Demand for streptavidin SPR chips mainly comes from biopharmaceutical R&D, CRO testing, antibody/ADC characterization, and early-stage small-molecule screening. The streptavidin–biotin system offers high affinity and good oriented immobilization, suitable for ligands that are easily inactivated after covalent coupling, require directional capture, or need stable, long-term repeated injections. Therefore, stable demand exists across Biacore, Octet SPR, OpenSPR, MP-SPR, and SPRi platforms.

On the supply side, the market shows a mix of platform-bound and compatible chips. Instrument vendors such as Cytiva and Sartorius leverage installed base and validation systems to maintain high pricing, while specialized surface suppliers like XanTec, BioNavis, and Reichert meet replacement demand through varied matrices, capacities, and compatible formats. Domestic SPR platforms are beginning to provide SA chips, but overall remain in the stage of import substitution and platform adaptation.

Future growth is primarily driven by drug discovery needs for high-throughput, low-sample-volume, and renewable capture surfaces. SA chips are not the most general-purpose chips—their market size is smaller than CM5/CM-dextran chips—but they have high unit prices, clear repurchase patterns, and are indispensable for biotinylated targets, antibody screening, nucleic acid aptamers, and membrane protein analyses. They are expected to maintain moderate growth above the overall life science consumables market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Streptavidin SPR Chip market?

What factors are driving Streptavidin SPR Chip market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Streptavidin SPR Chip market opportunities vary by end market size?

How does Streptavidin SPR Chip break out by Type, by Application?

This report presents a comprehensive overview of the global Streptavidin SPR Chip market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Pre-Immobilized Streptavidin
  • On-Chip Streptavidin Kit
  • Regenerable Streptavidin
  • Custom Streptavidin Surface
  • Other Capture Surface

Segment by Platform Format

  • Biacore Format
  • Octet SPR Format
  • OpenSPR Format
  • MP-SPR Slide
  • SPRi Array Format
  • Other Format

Segment by Capture Capacity

  • Low Capacity
  • Medium Capacity
  • High Capacity
  • Very High Capacity
  • Custom Capacity

Segment by Application

  • Protein Kinetics
  • Small-Molecule Screening
  • Antibody Characterization
  • Nucleic Acid Binding
  • Peptide Binding
  • Biomarker Assay Development
  • Biosensor Surface Development

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Streptavidin SPR Chip market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Protein Kinetics, Small-Molecule Screening, Antibody Characterization evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Streptavidin SPR Chip Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$51.85
2025
Forecast
$86
2032
CAGR
7.5%
2025–2032
Regions
5
global
Key companies
CytivaSartoriusNicoyaXanTecBioNavisBiosensing InstrumentReichertCarterra
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Pre-Immobilized StreptavidinOn-Chip Streptavidin KitRegenerable StreptavidinCustom Streptavidin SurfaceOther Capture Surface
By Application
Protein KineticsSmall-Molecule ScreeningAntibody CharacterizationNucleic Acid BindingPeptide BindingBiomarker Assay DevelopmentBiosensor Surface Development

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Pre-Immobilized Streptavidin
  • 3.1.3 On-Chip Streptavidin Kit
  • 3.1.4 Regenerable Streptavidin
  • 3.1.5 Custom Streptavidin Surface
  • 3.1.6 Other Capture Surface
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Protein Kinetics
  • 4.1.3 Small-Molecule Screening
  • 4.1.4 Antibody Characterization
  • 4.1.5 Nucleic Acid Binding
  • 4.1.6 Peptide Binding
  • 4.1.7 Biomarker Assay Development
  • 4.1.8 Biosensor Surface Development
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Cytiva
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Sartorius
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nicoya
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 XanTec
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BioNavis
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Biosensing Instrument
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Reichert
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Carterra
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Malvern Panalytical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Polariton Life
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Streptavidin SPR Chip market?
The global Streptavidin SPR Chip market is estimated at US$ 51.85 million in 2025 (base year) and is projected to reach US$ 84.4 million by 2032.
What is the forecast CAGR for the Streptavidin SPR Chip market?
The market is expected to grow at a CAGR of 7.5% from 2026 to 2032, expanding from US$ 51.85 million in 2025 to US$ 84.4 million in 2032, roughly 1.6 times its base-year value.
What is Streptavidin SPR Chip?
Streptavidin SPR chips are SPR consumables in which streptavidin is pre-immobilized or forms a streptavidin capture layer on gold films, prisms, or sensor substrates via accompanying reagents. They are used for high-affinity capture of biotinylated proteins, peptides, nucleic acids, glycans, and other ligands, enabling affinity, kinetics, and screening analyses. The product’s gross margin is approximately 62%.
How is the Streptavidin SPR Chip market segmented by type?
By type, the market is segmented into Pre-Immobilized Streptavidin, On-Chip Streptavidin Kit, Regenerable Streptavidin, Custom Streptavidin Surface and Other Capture Surface.
What are the key applications of Streptavidin SPR Chip?
Key applications covered include Protein Kinetics, Small-Molecule Screening, Antibody Characterization, Nucleic Acid Binding, Peptide Binding, Biomarker Assay Development and Biosensor Surface Development.
Which companies are profiled in the Streptavidin SPR Chip market report?
Key players profiled include Cytiva, Sartorius, Nicoya, XanTec, BioNavis, Biosensing Instrument, Reichert and Carterra, among 10 companies covered in total.
What geographies does the Streptavidin SPR Chip market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Streptavidin SPR Chip?
Future growth is primarily driven by drug discovery needs for high-throughput, low-sample-volume, and renewable capture surfaces.
Who should buy the Streptavidin SPR Chip market report?
The report is intended for manufacturers and solution providers, distributors and end users in Protein Kinetics, Small-Molecule Screening and Antibody Characterization, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Streptavidin SPR Chip market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.